Kalshi launches biotech prediction markets, topping $100,000 in early volume

The July 16 rollout lets users bet on Phase 3 trial outcomes and FDA drug approvals, while Polymarket has hosted similar biotech contracts since May.

CORE

28d ago

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.